Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Ilex Medical Ltd, founded in 1977 and headquartered in Petah Tikva, Israel, delivers comprehensive solutions to laboratories and healthcare providers, primarily operating in Israel and South Africa. The company specializes in the distribution, sale, and support of medical equipment, consumables, and chemical reagents. Its offerings encompass in vitro diagnostic systems for hospitals and clinics, alongside molecular biology products utilized for detecting cancer, retroviruses, tuberculosis, STDs, and other infectious agents. Ilex Medical also supplies equipment and reagents for in vitro fertilization, as well as for the food and pharmaceutical sectors. Furthermore, the company distributes and supports advanced nucleic acid testing solutions for major blood banks, offers pre/post analytical tools and robotics, and develops, markets, implements, and maintains laboratory information systems. A specialized portfolio includes molecular diagnostics, critical care, and immunology products.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD